Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Inventory (2020 - 2025)

Celularity has reported Inventory over the past 6 years, most recently at $2.6 million for Q3 2025.

  • Quarterly results put Inventory at $2.6 million for Q3 2025, down 35.33% from a year ago — trailing twelve months through Sep 2025 was $2.6 million (down 35.33% YoY), and the annual figure for FY2024 was $5.4 million, down 5.98%.
  • Inventory for Q3 2025 was $2.6 million at Celularity, down from $4.4 million in the prior quarter.
  • Over the last five years, Inventory for CELU hit a ceiling of $24.7 million in Q2 2022 and a floor of $2.6 million in Q3 2025.
  • Median Inventory over the past 5 years was $5.4 million (2024), compared with a mean of $6.8 million.
  • Biggest five-year swings in Inventory: plummeted 76.73% in 2023 and later surged 67.44% in 2025.
  • Celularity's Inventory stood at $9.5 million in 2021, then crashed by 44.41% to $5.3 million in 2022, then increased by 8.38% to $5.8 million in 2023, then fell by 5.98% to $5.4 million in 2024, then crashed by 52.62% to $2.6 million in 2025.
  • The last three reported values for Inventory were $2.6 million (Q3 2025), $4.4 million (Q2 2025), and $6.2 million (Q1 2025) per Business Quant data.